Clinical Trial Update: A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ZILRETTA (extended-release triamcinolone acetonide) versus immediate-release triamcinolone acetonide in hip osteoarthritis has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip

Drugs mentioned

• Triamcinolone acetonide (immediate-release) (triamcinolone acetonide)
• ZILRETTA (Triamcinolone acetonide extended-release injectable suspension)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of Hip | Phase 2 | Status: TERMINATED